The gang of seven concerned employees as AstraZeneca march forward with more details concerning their allegations of off-label marketing. This one could really blow up into something large, if the facts are straight. Check out the latest from Brandweek NRX and Peter Rost.
Lest you forget, AZ also makes Seroquel, and the lawsuits have already begun about the, um, liberal, marketing of that product. More on Seroquel's ever-expanding market here and here.
Showing posts with label Brandweek. Show all posts
Showing posts with label Brandweek. Show all posts
Friday, April 13, 2007
Tuesday, April 03, 2007
Rost Vindicated, Pfizer Slapped
Jim Edwards of Brandweek NRX called it. Peter Rost has talked about it for years. Pfizer pushed their human growth hormone product, Genotropin off-label, and has now settled a lawsuit for the sum of about $35 million. Big props to Rost for his excellent whistleblowing on this issue. I expect he'll have celebratory T-shirts and coffee mugs released by the end of the week!
Labels:
Brandweek,
Genotropin,
Peter Rost,
Pfizer
Tuesday, February 27, 2007
The Mask, Missing Safety Studies, WHO, and More
A few links to posts I've found notable and relevant the past few days, then likely not much more out of me for the day...
Pharma Giles insists on continually being funny. Just a heads up that the latest post there is laugh-inducing. It involves a Darth Vader mask, a Hannibal Lechter mask, satire regarding Exubera, and more.
Oh, and the rant on the Pharma Giles site from last week was a thing of beauty.
As if Exubera is not getting kicked around enough, Brandweek attempts to slam more nails into the coffin of the bong-like insulin inhaler. A great read.
Meanwhile, Furious Seasons was among the first to discuss some of Marcia Angell's prescient comments regarding the drug industry. Did you know, for example, that drug companies frequently promise the FDA that they will conduct studies regarding the safety of their products, yet about 70% of these studies have apparently never been conducted?? Are you kidding me?
PharmaGossip notes that Abbott is cutting scientists from its workforce. Hopefully the marketing staff is safe. Insider also notes that the counter-detailing movement has started. Yep, individuals are hitting doctors' offices armed with science rather than sales scripts, sometimes even suggesting (*gasp*) that physicians may want to prescribe older, less expensive treatments! Oh the horror! Could this movement catch on?
Last, but not least, Health Care Renewal has posted on the World Health Organization seemingly accepting money from drug companies after the money was first laundered by patient advocacy groups.
Pharma Giles insists on continually being funny. Just a heads up that the latest post there is laugh-inducing. It involves a Darth Vader mask, a Hannibal Lechter mask, satire regarding Exubera, and more.
Oh, and the rant on the Pharma Giles site from last week was a thing of beauty.
As if Exubera is not getting kicked around enough, Brandweek attempts to slam more nails into the coffin of the bong-like insulin inhaler. A great read.
Meanwhile, Furious Seasons was among the first to discuss some of Marcia Angell's prescient comments regarding the drug industry. Did you know, for example, that drug companies frequently promise the FDA that they will conduct studies regarding the safety of their products, yet about 70% of these studies have apparently never been conducted?? Are you kidding me?
PharmaGossip notes that Abbott is cutting scientists from its workforce. Hopefully the marketing staff is safe. Insider also notes that the counter-detailing movement has started. Yep, individuals are hitting doctors' offices armed with science rather than sales scripts, sometimes even suggesting (*gasp*) that physicians may want to prescribe older, less expensive treatments! Oh the horror! Could this movement catch on?
Last, but not least, Health Care Renewal has posted on the World Health Organization seemingly accepting money from drug companies after the money was first laundered by patient advocacy groups.
Subscribe to:
Posts (Atom)